SELLAS Life Sciences enters its pivotal REGAL readout with a transformed shareholder base, stronger balance sheet, and a new supply structure. Institutional ownership doubled to 36.34%, with average ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results